HIV-AIDS Cure News 2017: Nigerian Researcher Requests for His Developed Drug To Be Tested
In various countries around the world, researchers continue their studies to develop what they hope to become a cure for HIV-AIDS.
Recently, local reports shared that Nigerian researcher and University professor of Veterinary Medicine, Madubuike Ezeibe, was one of the latest scientists to come forward claiming to have possibly developed a cure for HIV-AIDS.
In an interview with the News Agency of Nigeria, Ezeibe asked the Nigerian federal government to test the HIV-AIDS treatment he had developed called Aluminum-Magnesium Silicate through a "clinical trial" that would officially declare it as safe for human consumption.
Get Our Latest News for FREE
Ezeibe shared in the interview that he had already presented AMS to various international organizations and gatherings, including the Ethnopharmacology conference in Chicago last May 2016. He claimed that no other researcher or institution has refuted his study and the viability of AMS as a treatment for HIV-AIDS.
Ezeibe called on the Nigerian government "to institute an inter-ministerial committee" that would lead the clinical trial across six centers in Nigeria. The said inter-ministerial committee would ideally be composed of representatives from the "federal Ministries of Health, Education, Environment as well as Science and Technology" while gathering up to "1000 sample patients."
In the reports, Ezeibe also explained how he found AMS to work as an HIV-AIDS cure.
He said AMS was very much smaller in size at 0.96 nanometers compared to HIV that "has molecules as big as 110 nanometers." Ezeibe further explained: "The particles of AMS are positively and negatively charged, while HIV-infected cells are positively charged."
He added: "The AMS are immune stimulants; one can use simple sugar (glucose) to transport charged molecules across the mucus membrane to the blood. Glucose helps to transport the drug to any part of the body, including 'the sanctuary', where other drugs cannot reach to attack the HIV-infected cells."
Ezeibe claimed he had already dealt with "no fewer than 500 HIV cases" in and out of Nigeria through referrals from various medical institutions.
